Top

Published in:

01-12-2014 | Original Article

Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population

Authors: Hitsohi Tanimukai, Kei Hirai, Hiroyoshi Adachi, Akane Kishi

Published in: Annals of Hematology | Issue 12/2014

Abstract

Patients with cancer frequently suffer from insomnia symptoms, and additionally, their family members also often experience these symptoms. The aim of this study was to investigate the prevalence of insomnia symptoms in both family members and patients with hematological malignancies. We conducted an observational cross-sectional study using a clinical self-reported questionnaire for sleep conditions, depressive symptoms (two-question method), and worries (five items that originated from the Brief Cancer Worry Inventory). One hundred twelve family members and 153 patients were investigated. A t test and Chi-square test were used to compare the prevalence of insomnia and depressive symptoms between family members and patients. Logistic regression was used to determine whether insomnia symptoms or worries related to patients’ disease had an impact on depressive symptoms. The presence of insomnia symptoms in family members (87 %) was significantly higher than that in patients (60 %, p < 0.001). The prevalence of depressive mood and anhedonia in family members were 55 and 34 %, respectively, and these values were higher than those in patients (43 and 28 %, respectively). Insomnia symptoms and worries about present/prospective disease conditions were significantly associated with depressive mood (insomnia symptoms, odds ratios (OR) 4.3, confidence intervals (CI) 1.2–15.2, p = 0.025; worries, OR 4.4, CI 1.0–19.3, p = 0.048). Taken together, our results demonstrated that insomnia symptoms and depressive symptoms are highly prevalent in family members as well as in patients with hematological malignancies.

Davidson JR, MacLean AW, Brundage MD, Schulze K (2002) Sleep disturbance in cancer patients. Soc Sci Med 54(9):1309–1321PubMedCrossRef

Ginsburg ML, Quirt C, Ginsburg AD, MacKillop WJ (1995) Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. CMAJ 152(5):701–708PubMedCentralPubMed

Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manag 9(6):372–382CrossRef

Krech RL, Walsh D (1991) Symptoms of pancreatic cancer. J Pain Symptom Manag 6(6):360–367CrossRef

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton L, Hoskins W et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3(3):183–189PubMedCrossRef

Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179PubMedCrossRef

Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262(11):1479–1484PubMedCrossRef

Weyerer S, Dilling H (1991) Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. Sleep 14(5):392–398PubMed

Doi Y (2009) Epidemiologic research on insomnia in the general Japanese populations. Nihon Rinsho 67(8):1463–1467PubMed

10.

Berger AM, Mitchell SA (2008) Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Cancer Netw 6(1):3–13

11.

Wielgus KK, Berger AM, Hertzog M (2009) Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 36(1):38–48. doi:10.1188/09.ONF.38-48 PubMedCrossRef

12.

Byar KL, Berger AM, Bakken SL, Cetak MA (2006) Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum 33(1):E18–E26. doi:10.1188/06.ONF.E18-E26 PubMedCrossRef

13.

O'Donnell JF (2004) Insomnia in cancer patients. Clin Cornerstone 6(Suppl 1D):S6–S14PubMedCrossRef

14.

Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L (2006) Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14(3):201–209. doi:10.1007/s00520-005-0861-0 PubMedCentralPubMedCrossRef

15.

Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S (2007) Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manag 33(4):398–409. doi:10.1016/j.jpainsymman.2006.09.022 CrossRef

16.

Kozachik SL, Bandeen-Roche K (2008) Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs 31(5):334–344. doi:10.1097/01.NCC.0000305769.27227.67 PubMedCentralPubMedCrossRef

17.

Tendas A, Niscola P, Cupelli L, Giovannini M, Scaramucci L, Ales M, Morino L, Dentamaro T, de Fabritiis P (2010) Sleep complaints in hospitalized Italian patients with hematological malignancies. Intern Med 49(15):1689, author reply 1391PubMedCrossRef

18.

Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN, Hanks GW (2009) Sleep-wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manag 38(6):860–870. doi:10.1016/j.jpainsymman.2009.04.025 CrossRef

19.

Braun M, Mikulincer M, Rydall A, Walsh A, Rodin G (2007) Hidden morbidity in cancer: spouse caregivers. J Clin Oncol 25(30):4829–4834. doi:10.1200/JCO.2006.10.0909 PubMedCrossRef

20.

Matthews BA (2003) Role and gender differences in cancer-related distress: a comparison of survivor and caregiver self-reports. Oncol Nurs Forum 30(3):493–499. doi:10.1188/03.ONF.493-499 PubMedCrossRef

21.

Fife BL, Monahan PO, Abonour R, Wood LL, Stump TE (2009) Adaptation of family caregivers during the acute phase of adult BMT. Bone Marrow Transplant 43(12):959–966. doi:10.1038/bmt.2008.405 PubMedCrossRef

22.

Futterman AD, Wellisch DK, Zighelboim J, Luna-Raines M, Weiner H (1996) Psychological and immunological reactions of family members to patients undergoing bone marrow transplantation. Psychosom Med 58(5):472–480PubMedCrossRef

23.

Vanderwerker LC, Laff RE, Kadan-Lottick NS, McColl S, Prigerson HG (2005) Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol 23(28):6899–6907. doi:10.1200/JCO.2005.01.370 PubMedCentralPubMedCrossRef

24.

Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC (2008) Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull 134(1):1–30. doi:10.1037/0033-2909.134.1.1 PubMedCrossRef

25.

Segrin C, Badger T, Dorros SM, Meek P, Lopez AM (2007) Interdependent anxiety and psychological distress in women with breast cancer and their partners. Psychooncology 16(7):634–643. doi:10.1002/pon.1111 PubMedCrossRef

26.

Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174. doi:10.1016/S1470-2045(11)70002-X PubMedCrossRef

27.

Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135(1–3):10–19. doi:10.1016/j.jad.2011.01.011 PubMedCrossRef

28.

Carter PA, Chang BL (2000) Sleep and depression in cancer caregivers. Cancer Nurs 23(6):410–415PubMedCrossRef

29.

Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E (2008) Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 11(3):422–427. doi:10.1089/jpm.2007.0184 PubMedCrossRef

30.

Whooley MA, Avins AL, Miranda J, Browner WS (1997) Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12(7):439–445PubMedCentralPubMedCrossRef

31.

Arroll B, Khin N, Kerse N (2003) Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ 327(7424):1144–1146. doi:10.1136/bmj.327.7424.1144 PubMedCentralPubMedCrossRef

32.

American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington, DC

33.

Hirai K, Shiozaki M, Motooka H, Arai H, Koyama A, Inui H, Uchitomi Y (2008) Discrimination between worry and anxiety among cancer patients: development of a Brief Cancer-Related Worry Inventory. Psychooncology 17(12):1172–1179. doi:10.1002/pon.1348 PubMedCrossRef

34.

Beattie S, Lebel S (2011) The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review. Psychooncology 20(11):1137–1150. doi:10.1002/pon.1962 PubMedCrossRef

35.

Allart P, Soubeyran P, Cousson-Gelie F (2013) Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature. Psychooncology 22(2):241–249. doi:10.1002/pon.3026 PubMed

36.

Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manag 42(3):432–442. doi:10.1016/j.jpainsymman.2010.12.008 CrossRef

37.

Zimmermann C, Yuen D, Mischitelle A, Minden MD, Brandwein JM, Schimmer A, Gagliese L, Lo C, Rydall A, Rodin G (2013) Symptom burden and supportive care in patients with acute leukemia. Leuk Res 37(7):731–736. doi:10.1016/j.leukres.2013.02.009 PubMedCrossRef

38.

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336PubMedCrossRef

39.

Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000) The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer 89(5):1162–1171. doi:10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y PubMedCrossRef

40.

Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manag 25(5):420–429CrossRef

41.

Carney S, Koetters T, Cho M, West C, Paul SM, Dunn L, Aouizerat BE, Dodd M, Cooper B, Lee K, Wara W, Swift P, Miaskowski C (2011) Differences in sleep disturbance parameters between oncology outpatients and their family caregivers. J Clin Oncol 29(8):1001–1006. doi:10.1200/JCO.2010.30.9104 PubMedCentralPubMedCrossRef

42.

Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R (2000) An epidemiological study of insomnia among the Japanese general population. Sleep 23(1):41–47PubMed

43.

van den Berg JF, Miedema HM, Tulen JH, Hofman A, Neven AK, Tiemeier H (2009) Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons. Sleep 32(10):1367–1375PubMedCentralPubMed

44.

Mitchell AJ, Meader N, Davies E, Clover K, Carter GL, Loscalzo MJ, Linden W, Grassi L, Johansen C, Carlson LE, Zabora J (2012) Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord 140(2):149–160. doi:10.1016/j.jad.2011.12.043 PubMedCrossRef

45.

Fujisawa D, Park S, Kimura R, Suyama I, Koyama Y, Takeuchi M, Yoshikawa H, Hashiguchi S, Shirahase J, Kato M, Takeda J, Kashima H (2010) Unmet supportive needs of cancer patients in an acute care hospital in Japan–a census study. Support Care Cancer 18(11):1393–1403. doi:10.1007/s00520-009-0761-9 PubMedCrossRef

46.

Rocha FL, Hara C, Rodrigues CV, Costa MA, Castro e Costa E, Fuzikawa C, Santos VG (2005) Is insomnia a marker for psychiatric disorders in general hospitals? Sleep Med 6(6):549–553. doi:10.1016/j.sleep.2005.04.008 PubMedCrossRef

47.

Neckelmann D, Mykletun A, Dahl AA (2007) Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30(7):873–880PubMedCentralPubMed

48.

Riemann D, Voderholzer U (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76(1–3):255–259PubMedCrossRef

Title: Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population
Authors: Hitsohi Tanimukai
Kei Hirai
Hiroyoshi Adachi
Akane Kishi
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 12/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-014-2139-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2014

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

Vitamin D deficiency and its correction in children with sickle cell anaemia

Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials